As of 2025-09-16, the Intrinsic Value of XBiotech Inc (XBIT) is -4.62 USD. This XBIT valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.72 USD, the upside of XBiotech Inc is -269.79%.
Based on its market price of 2.72 USD and our intrinsic valuation, XBiotech Inc (XBIT) is overvalued by 269.79%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.62 - -4.62 | -4.62 | -269.79% |
| P/E | (6.26) - (10.44) | (7.92) | -391.2% |
| DDM - Stable | (7.27) - (22.99) | (15.13) | -656.2% |
| DDM - Multi | (9.08) - (22.82) | (13.05) | -579.8% |
| Market Cap (mil) | 82.93 |
| Beta | 1.32 |
| Outstanding shares (mil) | 30.49 |
| Enterprise Value (mil) | -70.01 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.26% |
| Cost of Debt | 5.00% |
| WACC | 9.66% |